Explore expert-vetted resources on diseases of mind and sight.
In this timely discussion, Dr. Suzanne Schindler will explain how blood-based biomarkers are transforming Alzheimer’s diagnosis, research, and care.
Dr. Karl Wahlin explores how regenerative medicine and retinal cell replacement strategies could transform the future of glaucoma treatment and vision preservation.
Dr. Gil Rabinovici explores trontinemab, an investigational next-generation anti-amyloid therapy being studied for early Alzheimer’s disease.
Dr. April McCullough of Regeneron and Katherine Freund of Independent Transportation Network of America discuss the real-world barriers that prevent people with vision loss from accessing timely eye care and solutions that are available.
Dr. Zaldy Tan discusses what the newest research reveals about protecting brain health and promoting healthy aging.
Learn what the latest research tells us about what causes drusen and potential treatment options.
